The Clinical Lab Automation Market is expected to reach $4.01 billion by 2031, at a CAGR of 7.8% from 2024 to 2031. The growth of this market can be attributed to several factors, including the rising global geriatric population, increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. Moreover, the increasing demand for automated instruments, technological advancements in molecular diagnostics, and emerging economies are expected to offer growth opportunities for the players operating in the market.